Anonymous E-Mail Alleges GSK Bribery In Syria
This article was originally published in PharmAsia News
Executive Summary
In an apparent replay of the beginning of GlaxoSmithKline's compliance scandal in China, an anonymous e-mail has been sent to the UK-based multinational's top executives calling their attention to the alleged bribery of doctors and officials in Syria.